Clinical trials of agents that reverse multidrug resistance. A literature review

This publication has 35 references indexed in Scilit:

• Various Methods of Analysis of mdr-1/P-Glycoprotein in Human Colon Cancer Cell Lines
  JNCI Journal of the National Cancer Institute, 1992
• Monitoring the chemosensitizing effects of toremifene with flow cytometry in estrogen receptor negative multidrug resistant human breast cancer cells
  Breast Cancer Research and Treatment, 1992
• Adequate tumour quinidine levels for multidrug resistance modulation can be achieved in vivo
  European Journal Of Cancer, 1992
• Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin A
  European Journal of Cancer and Clinical Oncology, 1991
• Muscle metabolism and red cell ATP/ADP concentration during bicycle ergometer in patients with AMPD-deficiency
  Journal of Molecular Medicine, 1991
• An ethical look at intensive care for patients with malignancies
  European Journal of Cancer and Clinical Oncology, 1991
• Unknotting the Complexities of Multidrug Resistance: The Involvement of DNA Topoisomerases in Drug Action and Resistance
  JNCI Journal of the National Cancer Institute, 1989
• Enhancement of cytogenetic and cytotoxic effects on multidrug-resistant (MDR) cells by a calcium antagonist (verapamil)
  Mutation Research Letters, 1989
• The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humans
  American Heart Journal, 1985
• Correlation between potency of calmodulin inhibitors and effects on cellular levels and cytotoxic activity of Doxorubicin (Adriamycin) in resistant P388 mouse leukemia cells
  European Journal of Cancer and Clinical Oncology, 1984